Login / Signup

ROS-Generating Poly(Ethylene Glycol)-Conjugated Fe 3 O 4 Nanoparticles as Cancer-Targeting Sustained Release Carrier of Doxorubicin.

Boddu AdilakshmiObireddy Sreekanth ReddyDuddekunta HemalathaKummari Subba Venkata Krishna RaoWing-Fu Lai
Published in: International journal of nanomedicine (2022)
The reported conjugate shows anticancer potential, cancer-targeting ability, and ROS-generating capacity for effective drug encapsulation and sustained release in chemotherapy.
Keyphrases
  • cancer therapy
  • papillary thyroid
  • dna damage
  • cell death
  • drug delivery
  • squamous cell carcinoma
  • risk assessment
  • radiation therapy
  • young adults
  • human health
  • adverse drug